CHC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C (NCT01842451) | Vertex Pharmaceuticals Incorporated | 2013-06-01 |
Track CHC automatically
Every clearance here is in the API, with alerts when new ones post.